// Press Release
Increased Mobility of Patients Opens New Opportunities: Plastic Surgery is not High-Class Privilege Anymore
Increased Mobility of Patients Opens New Opportunities: Plastic Surgery is not High-Class Privilege Anymore Once the prerogative of the rich and famous, plastic surgery is now accessible to patients of all strata of society. Expert surgeons of Nordesthetics clinic explain the changing demographic features of their typical patient: a middle-class female. These patients typically have … Continue reading Increased Mobility of Patients Opens New Opportunities: Plastic Surgery is not High-Class Privilege Anymore
freport Uncovers Massive Price Gaps up to 3200% in CBD Products
Leafreport Uncovers Massive Price Gaps up to 3200% in CBD Products Leafreport has broken new ground with a market report that compares over 3,500 CBD products. TEL AVIV, ISRAEL — For an industry that’s projected to reach $20 billion by 2024 in the U.S. alone, the CBD (cannabidiol) market continues to baffle the general public. That is, until … Continue reading freport Uncovers Massive Price Gaps up to 3200% in CBD Products
New Treatment Approved in Canada for Most Common Type of Leukemia
New Treatment Approved in Canada for Most Common Type of Leukemia CALQUENCE® (acalabrutinib) is now available for adult patients with previously untreated and relapsed/refractory chronic lymphocytic leukemia MISSISSAUGA, ON, Jan. 8, 2020 /CNW/ – AstraZeneca Canada today announced that Health Canada has approved Calquence® (acalabrutinib), an oral Bruton’s tyrosine kinase (BTK) inhibitor, for the treatment of … Continue reading New Treatment Approved in Canada for Most Common Type of Leukemia
LQT Therapeutics Announces up to C$1.8M in Seed Funding Led by Fonds de solidarité FTQ to Accelerate Research of New Therapies for Long QT Syndrome
LQT Therapeutics Announces up to C$1.8M in Seed Funding Led by Fonds de solidarité FTQ to Accelerate Research of New Therapies for Long QT Syndrome LAVAL, QC, Jan. 8, 2020 /CNW Telbec/ – LQT Therapeutics, Inc. (“LQTT”), a newly formed life-science company, today announced it has raised up to C$1.8 Million in seed funding led by … Continue reading LQT Therapeutics Announces up to C$1.8M in Seed Funding Led by Fonds de solidarité FTQ to Accelerate Research of New Therapies for Long QT Syndrome
New possible strategy for treating chronic pain due to burns may help sufferers including veterans
New possible strategy for treating chronic pain due to burns may help sufferers including veterans UNDER STRICT EMBARGO UNTIL 01.00 GMT 10 JANUARY 2019 Not for publication or broadcast before this time New research shows how second-degree burns cause hard-to-treat chronic pain, and this understanding may be key to treating these complications, common in war veterans This research, published … Continue reading New possible strategy for treating chronic pain due to burns may help sufferers including veterans
High-Tech Stress-Relief System Seen As New Profit Center for Spas, Health and Fitness Centers
High-Tech Stress-Relief System Seen As New Profit Center for Spas, Health and Fitness Centers … Continue reading High-Tech Stress-Relief System Seen As New Profit Center for Spas, Health and Fitness Centers
Tobacco users likely to use regulation loopholes as 34% of global consumers still smoke regularly/occasionally, says GlobalData
Tobacco users likely to use regulation loopholes as 34% of global consumers still smoke regularly/occasionally, says GlobalData Following recent news of changes in UK and US regulation surrounding cigarettes and e-cigarettes, respectively; Hakan Demirci, Consumer Analyst at GlobalData, a leading data and analytics company, offers his view on the matter: “The UK’s restrictions of methanol … Continue reading Tobacco users likely to use regulation loopholes as 34% of global consumers still smoke regularly/occasionally, says GlobalData
AbbVie Receives Health Canada Approval of RINVOQ® (upadacitinib)
AbbVie Receives Health Canada Approval of RINVOQ® (upadacitinib), an Oral Medication for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis Approval supported by efficacy and safety data from the pivotal Phase 3 SELECT rheumatoid arthritis (RA) program, one of the largest registrational Phase 3 programs in RA with approximately 4,400 patients evaluated … Continue reading AbbVie Receives Health Canada Approval of RINVOQ® (upadacitinib)
Are your children sleeping enough? New research points to blood test that might hold the answer UNDER STRICT EMBARGO UNTIL 01.00 GMT 9 JANUARY 2020 Not for publication or broadcast before this time A simple blood test could provide a reliable metric to tell if children are sleeping enough – which is also a marker for general health as sleep affects susceptibility to many diseases – according to new … Continue reading
Smart Choices for a Good Health Reset
Smart Choices for a Good Health ResetResearch Shows Peanuts Support a Healthy Diet Albany, Ga. (January 7, 2020) – When it comes to health and wellness, it’s OK to start small. In fact, a good health reset is often most successful when smart, small, sustainable changes are made. Dr. Samara Sterling, research director with The Peanut Institute, says … Continue reading Smart Choices for a Good Health Reset
